The results
In the end, Pentalog developed the iOS and Android versions of the ARYSTM me patient app, the ARYSTM pro iOS professional app, and the e-commerce website. The Android version of the patient app by our Iasi team had a development deadline of just four weeks, to get it ready for an event. To do this successfully, we ramped up the team with senior developers and were able to publish the app to the Google Play store by the deadline.
Afterwards, we finished the other applications that had looser deadlines. We were able to be flexible and ramp the development teams up and down as needed, to cross new milestones and get the products ready for different event presentations. We also performed a technical audit on the ARYSTM me tracker itself to ensure it was up and running at full capacity.
Pentalog also ended up hosting yband therapy AG’s website. They were looking for a new hosting service and chose to go with ours, although it was more expensive than their first provider. Our level of support, reactivity, capacity, and security made the service worth the higher price. While our hosting services are competitively priced, they do cost more than the basic package due to the full-service capacity of our offer.
yband therapy AG was happy with the collaboration, and the work environment was a cooperative one. Their CTO served as a product owner, who was always available, open to technical suggestions, and always ready to discuss project issues. The customer appreciated how flexible we were and our ability to provide more resources when deadlines were approaching. They even recommended us to another startup!
This project is currently in maintenance phase, as all products are now available on the market. However, as the product continues to grow in popularity, we may help move the whole project to the cloud and work on big data processing. We look forward to watching yband therapy AG develop on the market and hope to continue working with them in the future.
More about MedTech apps: Pentalog builds a MedTech app for AMA OPTICS, INC.